[go: up one dir, main page]

WO2000071555A3 - 509rr - Google Patents

509rr Download PDF

Info

Publication number
WO2000071555A3
WO2000071555A3 PCT/US2000/011918 US0011918W WO0071555A3 WO 2000071555 A3 WO2000071555 A3 WO 2000071555A3 US 0011918 W US0011918 W US 0011918W WO 0071555 A3 WO0071555 A3 WO 0071555A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
methods
utilizing
screen
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/011918
Other languages
French (fr)
Other versions
WO2000071555A2 (en
Inventor
Weonhye Bae
Horn Stephanie Van
Richard L Warren
Sanjoy Biswas
John P Throup
Martin K R Burnham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of WO2000071555A2 publication Critical patent/WO2000071555A2/en
Publication of WO2000071555A3 publication Critical patent/WO2000071555A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1223—Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides 509RR polypeptides and polynucleotides encoding 509RR polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing 509RR polypeptides to screen for antibacterial compounds.
PCT/US2000/011918 1999-05-06 2000-05-03 509rr Ceased WO2000071555A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13293599P 1999-05-06 1999-05-06
US60/132,935 1999-05-06

Publications (2)

Publication Number Publication Date
WO2000071555A2 WO2000071555A2 (en) 2000-11-30
WO2000071555A3 true WO2000071555A3 (en) 2001-05-31

Family

ID=22456248

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/011917 Ceased WO2000067783A1 (en) 1999-05-06 2000-05-03 509hk
PCT/US2000/011918 Ceased WO2000071555A2 (en) 1999-05-06 2000-05-03 509rr

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2000/011917 Ceased WO2000067783A1 (en) 1999-05-06 2000-05-03 509hk

Country Status (1)

Country Link
WO (2) WO2000067783A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3342854A1 (en) 2015-08-26 2018-07-04 Universidad Pública De Navarra Mutant strains of staphylococcus aureus with multiple inactivated tcs systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744338A (en) * 1996-01-19 1998-04-28 Smithkline Beecham P.L.C. DNA encoding seryl tRNA synthetase from Staphylococcus aureus
US5846772A (en) * 1995-12-22 1998-12-08 Smithkline Beecham P.L.C. Two component signal transduction system response regulator polynucleotides of Staphylococcus aureus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846772A (en) * 1995-12-22 1998-12-08 Smithkline Beecham P.L.C. Two component signal transduction system response regulator polynucleotides of Staphylococcus aureus
US5744338A (en) * 1996-01-19 1998-04-28 Smithkline Beecham P.L.C. DNA encoding seryl tRNA synthetase from Staphylococcus aureus

Also Published As

Publication number Publication date
WO2000071555A2 (en) 2000-11-30
WO2000067783A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
EP0841394A3 (en) Staphylococcus aureus polynucleotides, polypeptides and their uses
WO1999058562A3 (en) Novel compounds
EP0899334A3 (en) FtsZ polypeptides from Streptococcus pneumoniae
WO2000044778A8 (en) mvk
WO2000061787A3 (en) gyrA
EP0881297A3 (en) Histidine kinase
EP0894857A3 (en) SecA gene from Streptococcus pneumoniae
EP0906955A3 (en) FtsY
WO2000065026A3 (en) YycG
WO2000071555A3 (en) 509rr
WO2000043491A3 (en) yhxB
EP0881286A3 (en) Histidine kinase
WO1999061453A3 (en) priA
EP0916730A3 (en) FabH from Staphylococcus aureus
EP0892059A3 (en) Histidine kinase polypeptides
EP0885965A3 (en) Histidine kinase polypeptides
EP0889128A3 (en) midA1 polypeptides from Streptococcus pneumoniae
EP0927763A3 (en) Novel aroA
WO1999055900A3 (en) Gcp
WO2000025818A8 (en) asuE/trmU
WO2001055331A3 (en) thdF
EP0909820A3 (en) Histidine kinase from Staphylococcus pneumoniae
EP0905247A3 (en) MurF polynucleotides and polypeptides from Staphylococcus
EP0899335A3 (en) MurB gene from Staphylococcus aureus
EP0874053A3 (en) 3-Dehydroquinate synthase (aroB)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP